Biomarker Panels for Predicting Progression of Kidney Disease in Acute Kidney Injury Survivors.
Menez S, Kerr K, Cheng S, Hu D, Thiessen-Philbrook H, Moledina D, Mansour S, Go A, Ikizler T, Kaufman J, Kimmel P, Himmelfarb J, Coca S, Parikh C. Biomarker Panels for Predicting Progression of Kidney Disease in Acute Kidney Injury Survivors. Clinical Journal Of The American Society Of Nephrology 2024 PMID: 39671257, DOI: 10.2215/cjn.0000000622.Peer-Reviewed Original ResearchAcute kidney injurySoluble tumor necrosis factor receptor 1End-stage kidney diseaseChronic kidney diseaseKidney diseaseFollow-upPost-AKI careDevelopment of end-stage kidney diseaseKidney-specific outcomesYears of follow-upCombination of clinical variablesReceiver-operating characteristic curveTumor necrosis factor receptor 1Progression of kidney diseaseSequelae of acute kidney injuryAdverse kidney eventsAge of study participantsAcute kidney injury survivorsDiuretic useEGFR declineKidney disease riskKidney eventsAKI patientsKidney injuryPost-discharge follow-upEarly, Individualized Recommendations for Hospitalized Patients With Acute Kidney Injury
Aklilu A, Menez S, Baker M, Brown D, Dircksen K, Dunkley K, Gaviria S, Farrokh S, Faulkner S, Jones C, Kadhim B, Le D, Li F, Makhijani A, Martin M, Moledina D, Coronel-Moreno C, O’Connor K, Shelton K, Shvets K, Srialluri N, Tan J, Testani J, Corona-Villalobos C, Yamamoto Y, Parikh C, Wilson F, Sundararajan A, Wang A, Schretlen C, Singel D, Moss E, Aune F, Iantosca G, Zou G, Chernova I, Bitzel J, Hernandez J, Lindsley J, Dane K, Orias M, Mehta P, Zassman-Isner S, Wen Y, Freeman N. Early, Individualized Recommendations for Hospitalized Patients With Acute Kidney Injury. JAMA 2024, 332 PMID: 39454050, DOI: 10.1001/jama.2024.22718.Peer-Reviewed Original ResearchElectronic health recordsUsual careHealth recordsAction teamsClinicians of patientsHospitalized patientsFinal follow-upIntervention groupHealth systemStudy pharmacistsStudy physiciansMain OutcomesAssociated with adverse outcomesAcute kidney injuryRandomized clinical trialsPrimary outcomeIndividualized recommendationsNew HavenAdverse outcomesAKI detectionCareRhode IslandComposite outcomeFollow-upIntervention